[26-002822] nhlbi DR young lab members requires hematology panel: sequencing somatic mutations in bone marrow samples. Results from this test provide guidance in treatment/diagnosis of disease.
Ended Purchase Order Awarded Last action
- Contract number
- 75N92026P00052
- Awardee
-
Genomic Testing Cooperative, LCA UEI NMAYSL9NW6M9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Forest, CA 92630, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung and Blood Institute (NHLBI) awarded a $24,000 firm fixed-price purchase order to Genomic Testing Cooperative, LCA, a small disadvantaged business based in Lake Forest, California, on January 20, 2026. The contract, which has no set-aside designation, requires the contractor to perform hematology panel sequencing on bone marrow samples to identify somatic mutations for the NHLBI's Young Lab. The resulting genetic analysis provides critical guidance for disease diagnosis and treatment decisions, leveraging the contractor's specialized 177-gene next-generation sequencing panel designed to detect mutations relevant to blood disorders and hematologic conditions.
This award represents a continuation of an established relationship between NHLBI and Genomic Testing Cooperative, which has received multiple contract awards since 2021 totaling over $650,000 for similar genomic testing services. The contractor's specialized capabilities in tumor profiling and cancer biomarker analysis directly support NHLBI's mission to advance understanding of blood, heart, and lung diseases through precision molecular diagnostics. The contract is scheduled for completion by September 1, 2026, and maintains the firm fixed-price structure typical of NHLBI's engagement with this vendor for routine genomic testing services supporting federal biomedical research initiatives.
Quick answers
Who was awarded contract 75N92026P00052?
75N92026P00052 was awarded to Genomic Testing Cooperative, LCA by National Heart Lung and Blood Institute (National Institutes of Health) on January 20, 2026.
How much is contract 75N92026P00052 worth?
The government has obligated $24,000 on 75N92026P00052.
Was contract 75N92026P00052 competed?
The extent of competition for 75N92026P00052 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award